A Randomised, Double-blind, Double-dummy, Parallel-group Multicentre Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Non-malignant Pain Taking Oxycodone Equivalent of 60-80 mg/Day as Oxycodone/Naloxone Prolonged Release Compared to Subjects Taking Oxycodone Prolonged Release Tablets Alone

Trial Profile

A Randomised, Double-blind, Double-dummy, Parallel-group Multicentre Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Non-malignant Pain Taking Oxycodone Equivalent of 60-80 mg/Day as Oxycodone/Naloxone Prolonged Release Compared to Subjects Taking Oxycodone Prolonged Release Tablets Alone

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2014

At a glance

  • Drugs Oxycodone; Oxycodone/naloxone
  • Indications Back pain; Constipation; Pain
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Mundipharma GmbH
  • Most Recent Events

    • 02 Sep 2010 Results presented at the 13th World Congress on Pain.
    • 28 Jul 2009 Planned end date changed from Feb 2008 to Jul 2008 as reported by ClinicalTrials.gov.
    • 16 Oct 2008 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top